Replies to post #10403 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Notes on Pharming Group, NV

[Updated for US phase-3 Rhucin data.]


#msg-30035067 Phase-3 Rhucin data (US)
#msg-22482530 Pharming seeks US Rhucin partner
#msg-22208171 Phase-3 Rhucin data (Europe)
#msg-27808107 EMEA rejects Rhucin re-examination

#msg-28598316 1Q08 financial results
#msg-28546713 Update from 2008 annual meeting
#msg-28738755 New program in “aging”

#msg-18949245 IP cross-license with GTC
#msg-27220955 Pharming licenses cattle IP from ACTC